Navigation Links
InterMune Reports Second Quarter 2008 Financial Results and Business Highlights
Date:7/31/2008

n its current fiscal year, which ends

on March 31, 2009.

ITMN-191 Program in HCV:

-- Assuming submitted abstracts will be accepted, InterMune expects to

present several abstracts on ITMN-191 at AASLD, scheduled for

October 31 - November 4 in San Francisco. These abstracts pertain

to various clinical studies on ITMN-191 and in-vitro studies of

ITMN-191 in combination with other direct antiviral compounds.

-- InterMune expects to announce top-line results from the currently

running 14-day study of ITMN-191 in combination with Pegasys and

ribavirin in the fourth quarter of 2008.

Conference Call and Webcast Details

InterMune will host a conference call today at 4:30 p.m. EDT to discuss its financial results for the second quarter 2008, its forward-looking financial guidance and its clinical development programs. Interested investors and others may participate in the conference call by dialing 888-799-0528 (U.S.) or 706-634-0154 (international), conference ID# 57393097. A replay of the webcast and teleconference will be available approximately three hours after the call.

To access the webcast, please log on to the company's website at http://www.intermune.com at least 15 minutes prior to the start of the call to ensure adequate time for any software downloads that may be required.

The teleconference replay will be available for 10 business days following the call and can be accessed by dialing 800-642-1687 (U.S.) or 706-645-9291 (international), and entering the conference ID# 57393097. The webcast will remain available on the company's website until the next earnings call.

About InterMune

InterMune is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and hepatology. InterMune has a pipeline portfo
'/>"/>

SOURCE InterMune, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. InterMune to Present at Thomas Weisel and Bear Stearns Healthcare Conferences
2. InterMune Announces Proposed Public Offering of Common Stock
3. InterMune Announces Pricing of $68 Million Public Offering of Common Stock
4. InterMune Announces Closing of Public Offering of Common Stock
5. InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance
6. InterMune to Present at the SIGnificant Options in Healthcare Conference
7. Evotec Expands Collaboration With InterMune
8. Statement by InterMune, Inc. Regarding Justice Department Action Against Former Employee for Past Conduct
9. InterMune to Present at Deutsche Bank Health Care Conference
10. InterMune to Present at Bank of America Health Care Conference
11. InterMune to Present at Citigroup Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... A recent study from researchers in ... find that those who took probiotics were able to run ... study showed that in extreme heat conditions, probiotics were able ... acne treatment explains what this new discovery means ... their skin condition. , While researchers tote the benefits ...
(Date:5/21/2013)... PALM BEACH, Fla. , May 21, 2013 ... (NYSE: FCN ), the global business ... enhance their enterprise value (the "Company"), announced that ... focused personnel that were formerly included within the ... and Litigation Consulting segment to form a single ...
(Date:5/21/2013)... study led by George Washington University Professor Tianshu ... ice in small droplets is strongly size-dependent, an ... nanoscale. The formation of ice at the nanoscale ... answer also has important implications for climate research ... ice from supercooled water is generally initiated by ...
(Date:5/21/2013)... Clinverse, Inc. , a ... trials, announced today it has formed a strategic ... ClinPay® FLS eClinical commerce platform aggregates data collected ... SpendMD ™, Aggregate Spend Solutions’ recently-launched flagship product, ... reporting transfer of value at investigator meetings or ...
Breaking Biology Technology:Adult Acne Treatment, Probiotic Action Shares Insight on New Findings Between Probiotics and Heat Tolerance, and What It Means for Acne Sufferers 2FTI Consulting Releases Realigned Segment Information Reflecting Newly Combined Health Solutions Practice 2Study led by GW professor provides better understanding of water's freezing behavior at nanoscale 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3
... controversy over its proposed overhaul of the state's healthcare system ... pare back additional funding for the Act 255 tax credit ... Joint Committee on Finance. , ,The caucus voted to delete ... investment and early-stage seed investment tax credits. , ,According ...
... up in the scandals of WorldCom, ENRON, and TYCO were heartless ... The people on this video make them look like saints. Why? ... trying to make a living to support their families. , ,Think ... last couple of years that have not been able to find ...
... - Cambridge Major Laboratories , a Germantown ... executive James Davidson as its chief operating officer. ... a global expansion strategy, places Davidson in charge ... years in the industry, Davidson has worked for ...
Cached Biology Technology:Senate Democrats strip additional Act 255 funding from budget 2A disgusting video: U.S. companies sell out Americans 2A disgusting video: U.S. companies sell out Americans 3A disgusting video: U.S. companies sell out Americans 4
(Date:5/22/2013)... 22, 2013. Plastic additives known as phthalates (pronounced ... They turn up in flooring, plastic cups, beach ... Centers for Disease Control and Preventionthe bodies of ... come under increasing scrutiny. A growing collection of ... leech from packaging and mix with food) may ...
(Date:5/21/2013)... cells in the blood often jump into action ... that can fight off illness. But repeated infections ... leading to the development of serious blood conditions ... led by biologists at the California Institute of ... the molecule microRNA-146a (miR-146a) acts as a critical ...
(Date:5/21/2013)... and health stores, phosphatidylserine is a natural food ... to improve cognition and slow memory loss, it,s ... impairment. Now a team headed by Prof. Gil ... University,s Department of Human Molecular Genetics ... functioning of genes involved in degenerative brain disorders, ...
Breaking Biology News(10 mins):Study links chemicals widely found in plastics and processed food to elevated blood pressure in children and teens 2Keeping stem cells strong 2Common food supplement fights degenerative brain disorders 2
... Gamers have solved the structure of a retrovirus ... a decade. The gamers achieved their discovery by ... collaborate and compete in predicting the structure of protein ... the structure of a protein-cutting enzyme from an AIDS-like ...
... 2011 -- Durum wheat is a valuable cereal crop ... Canada, and several European countries. Scab or Fusarium head ... reducing its grain yield and quality. Current durum cultivars ... While working on the Durum Germplasm Enhancement Project (DGE), ...
... PITTSBURGH, Sept. 16 Researchers at the University of ... the brains of women with major depressive disorder that ... to the illness. Their results, published online this week ... changes in a mouse model that could enhance future ...
Cached Biology News:Gamers succeed where scientists fail 2Gamers succeed where scientists fail 3Pitt team finds molecular evidence of brain changes in depressed females 2
... Cyno Serum • Cyno serum is collected off the ... 5-7 years of age. Available Anticoagulants: ... N-06: K2EDTA N-08: Potassium Oxalate ... N-05: ACD N-07: CPD ...
All serum is collected from adult animals aged 6 months or older. Certified U.S. orgin. Pricing: $35/unit for 1 - 10 units...
adult...
DNA Purification...
Biology Products: